These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 27462068)

  • 41. Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register.
    Humphries SE; Cooper JA; Seed M; Capps N; Durrington PN; Jones B; McDowell IFW; Soran H; Neil HAW;
    Atherosclerosis; 2018 Jul; 274():41-46. PubMed ID: 29751283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statin pretreatment and presentation patterns in patients with coronary artery disease.
    Ndrepepa G; Fusaro M; King L; Cassese S; Tada T; Schömig A; Kastrati A
    Cardiol J; 2013; 20(1):52-8. PubMed ID: 23558811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patients with Acute Coronary Syndrome are at High Risk Prior to the Event and Lipid Management is Underachieved Pre- and Post- Hospitalization.
    Vlachopoulos C; Andrikopoulos G; Terentes-Printzios D; Tzeis S; Iliodromitis EK; Richter D; Mantas I; Kartalis A; Vasilikos V; Stakos D; Patsilinakos S; Lampropoulos S; Symeonidis D; Kyrpizidis C; Marinakis N; Nikas N; Lekakis J; Tousoulis D; Vardas P
    Curr Vasc Pharmacol; 2018; 16(4):405-413. PubMed ID: 28676022
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of statin therapy on the prevention of new-onset acute coronary syndrome in patients with rheumatoid arthritis.
    Huang CY; Lin TT; Yang YH; Lin LY; Tsai CT; Hwang JJ; Chen PC; Lin JL
    Int J Cardiol; 2018 Feb; 253():1-6. PubMed ID: 29174015
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-Study.
    Iannaccone M; D Ascenzo F; De Filippo O; Gagliardi M; Southern DA; Raposeiras-Roubín S; Abu-Assi E; Henriques JPS; Saucedo J; González-Juanatey JR; Wilton SB; Kikkert WJ; Nuñez-Gil I; Ariza-Sole A; Song X; Alexopoulos D; Liebetrau C; Kawaji T; Huczek Z; Nie SP; Fujii T; Correia L; Kawashiri MA; García-Acuña JM; Alfonso E; Terol B; Garay A; Zhang D; Chen Y; Xanthopoulou I; Osman N; Möllmann H; Shiomi H; Kowara M; Filipiak K; Wang X; Yan Y; Fan JY; Ikari Y; Nakahashi T; Sakata K; Yamagishi M; Moretti C; Gaita F; Kalpak O; Kedev S
    Am J Cardiovasc Drugs; 2017 Feb; 17(1):61-71. PubMed ID: 27738920
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Lipid profile, familial hypercholesterolemia prevalence, and 2-year cardiovascular outcome assessment in acute coronary syndrome: Real-life data of a retrospective cohort].
    Kayikcioglu M; Alan B; Payzın S; Can LH
    Turk Kardiyol Dern Ars; 2019 Sep; 47(6):476-486. PubMed ID: 31483296
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exploration into lipid management and persistent risk in patients hospitalised for acute coronary syndrome in Japan (EXPLORE-J): protocol for a prospective observational study.
    Nakamura M; Uno K; Hirayama A; Ako J; Nohara A; Arai H; Harada-Shiba M
    BMJ Open; 2017 Jul; 7(6):e014427. PubMed ID: 28674132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Management of hypercholesterolemia in patients with acute coronary syndrome: current mechanisms and future perspectives].
    Lettino M
    G Ital Cardiol (Rome); 2016 Apr; 17(4 Suppl 1):31S-7. PubMed ID: 27312021
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prescription of statins at discharge and 1-year risk of major clinical outcomes among acute coronary syndromes patients with extremely low LDL-cholesterol in clinical pathways for acute coronary syndromes studies.
    Sun Y; Xie G; Patel A; Li S; Zhao W; Yang X; Wu T; Li M; Li X; Du X; Hu R; Huo Y; Hu D; Gao RL; Wu Y
    Clin Cardiol; 2018 Sep; 41(9):1192-1200. PubMed ID: 30084224
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical implications of switching from intensive to moderate statin therapy after acute coronary syndromes.
    Colivicchi F; Tubaro M; Santini M
    Int J Cardiol; 2011 Oct; 152(1):56-60. PubMed ID: 20674999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromes.
    Elbarouni B; Ismaeil N; Yan RT; Fox KA; Connelly KA; Baer C; DeYoung JP; Gallo R; Ramanathan K; Pesant Y; Leiter LA; Goodman SG; Yan AT
    Am Heart J; 2011 Aug; 162(2):347-355.e1. PubMed ID: 21835297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS patient pathway project.
    Landmesser U; Pirillo A; Farnier M; Jukema JW; Laufs U; Mach F; Masana L; Pedersen TR; Schiele F; Steg G; Tubaro M; Zaman A; Zamorano P; Catapano AL
    Atheroscler Suppl; 2020 Dec; 42():e49-e58. PubMed ID: 33589224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment and outcomes of patients with suspected acute coronary syndromes in relation to initial diagnostic impressions (insights from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE]).
    Bajaj RR; Goodman SG; Yan RT; Bagnall AJ; Gyenes G; Welsh RC; Eagle KA; Brieger D; Ramanathan K; Grondin FR; Yan AT;
    Am J Cardiol; 2013 Jan; 111(2):202-7. PubMed ID: 23122889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Late Consequences of Acute Coronary Syndromes: Global Registry of Acute Coronary Events (GRACE) Follow-up.
    Alnasser SM; Huang W; Gore JM; Steg PG; Eagle KA; Anderson FA; Fox KA; Gurfinkel E; Brieger D; Klein W; van de Werf F; Avezum Á; Montalescot G; Gulba DC; Budaj A; Lopez-Sendon J; Granger CB; Kennelly BM; Goldberg RJ; Fleming E; Goodman SG;
    Am J Med; 2015 Jul; 128(7):766-75. PubMed ID: 25554379
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anaemia to predict outcome in patients with acute coronary syndromes.
    Ennezat PV; Maréchaux S; Pinçon C; Finzi J; Barrailler S; Bouabdallaoui N; Van Belle E; Montalescot G; Collet JP
    Arch Cardiovasc Dis; 2013; 106(6-7):357-65. PubMed ID: 23806304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.
    Sahebkar A; Watts GF
    Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular Risk Factors and In-hospital Mortality in Acute Coronary Syndromes: Insights From the Canadian Global Registry of Acute Coronary Events.
    Wang JY; Goodman SG; Saltzman I; Wong GC; Huynh T; Dery JP; Leiter LA; Bhatt DL; Welsh RC; Spencer FA; Fox KA; Yan AT; ;
    Can J Cardiol; 2015 Dec; 31(12):1455-61. PubMed ID: 26143140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early, intensive statin treatment reduces 'hard' cardiovascular outcomes after acute coronary syndrome.
    Schwartz GG; Fayyad R; Szarek M; DeMicco D; Olsson AG
    Eur J Prev Cardiol; 2017 Aug; 24(12):1294-1296. PubMed ID: 28504565
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Killip classification in patients with acute coronary syndrome: insight from a multicenter registry.
    El-Menyar A; Zubaid M; AlMahmeed W; Sulaiman K; AlNabti A; Singh R; Al Suwaidi J
    Am J Emerg Med; 2012 Jan; 30(1):97-103. PubMed ID: 21159479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute coronary syndrome in young adults: the Thai ACS Registry.
    Tungsubutra W; Tresukosol D; Buddhari W; Boonsom W; Sanguanwang S; Srichaiveth B;
    J Med Assoc Thai; 2007 Oct; 90 Suppl 1():81-90. PubMed ID: 18431890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.